| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Exenatide | FAERS: 105 | US FAERS | |
| 2 | Teriparatide | FAERS: 34 | US FAERS | |
| 3 | Risperidone | FAERS: 28 | US FAERS | |
| 4 | Epinephrine | FAERS: 21 | OFFSIDES US FAERS | |
| 5 | reviparin | FAERS: 16 | US FAERS | |
| 6 | Sumatriptan | FAERS: 6 | US FAERS | |
| 7 | Fondaparinux | FAERS: 5 | OFFSIDES US FAERS | |
| 8 | Vitamin K 1 | FAERS: 5 | OFFSIDES US FAERS | |
| 9 | Alprostadil | FAERS: 4 | OFFSIDES US FAERS | |
| 10 | Enfuvirtide | FAERS: 4 | US FAERS | |
| 11 | Insulin Detemir | FAERS: 2 | US FAERS | |
| 12 | Apomorphine | FAERS: 1 | US FAERS | |
| 13 | Carboplatin | FAERS: 1 | US FAERS | |
| 14 | Clozapine | FAERS: 1 | US FAERS | |
| 15 | Cyclophosphamide | FAERS: 1 | US FAERS | |
| 16 | Etoposide | FAERS: 1 | US FAERS | |
| 17 | Gefitinib | FAERS: 1 | US FAERS | |
| 18 | Insulin Glargine | FAERS: 1 | US FAERS | |
| 19 | Leuprolide | FAERS: 1 | US FAERS | |
| 20 | Octreotide | FAERS: 1 | US FAERS | |
| 21 | pramlintide | FAERS: 1 | US FAERS | |
| 22 | rofecoxib | FAERS: 1 | US FAERS | |
| 23 | ziprasidone | FAERS: 1 | US FAERS | |
| 24 | Azathioprine | OFFSIDES | ||
| 25 | Budesonide | OFFSIDES | ||
| 26 | Duloxetine Hydrochloride | OFFSIDES | ||
| 27 | Fluticasone-Salmeterol Drug Combination | OFFSIDES | ||
| 28 | Fosinopril | OFFSIDES | ||
| 29 | Glipizide | OFFSIDES | ||
| 30 | Hydroxychloroquine | OFFSIDES | ||
| 31 | Lamotrigine | OFFSIDES | ||
| 32 | Leucovorin | OFFSIDES | ||
| 33 | Mesalamine | OFFSIDES | ||
| 34 | Methocarbamol | OFFSIDES | ||
| 35 | Nateglinide | OFFSIDES | ||
| 36 | Sumatriptan | OFFSIDES | ||
| 37 | Triamterene | OFFSIDES | ||
| 38 | gadoversetamide | OFFSIDES | ||
| 39 | moexipril | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.